Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
China flag China · Delayed Price · Currency is CNY
11.23
-0.17 (-1.49%)
Nov 6, 2026, 11:15 AM CST

SHE:300583 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
234.05295.07255.96238.49188.4161.5
Cash & Short-Term Investments
234.05295.07255.96238.49188.4161.5
Cash Growth
2.46%15.28%7.33%26.59%16.66%-53.12%
Accounts Receivable
468.45485.37336.71383.2285.22301.81
Other Receivables
2.187.1213.0422.7311.5511.77
Receivables
470.63492.48349.75405.93296.77313.58
Inventory
543.6477.24644.88722.62608.26531.26
Prepaid Expenses
----2.13-
Other Current Assets
44.0119.7434.3330.7444.3873.97
Total Current Assets
1,2921,2851,2851,3981,1401,080
Property, Plant & Equipment
1,4121,3941,4611,5561,6061,643
Long-Term Investments
76.0374.0468.6865.1263.259.18
Other Intangible Assets
178.3182.86189.15200.58172.9178.85
Long-Term Deferred Tax Assets
12.4913.1116.211.278.951.93
Long-Term Deferred Charges
0.380.610.791.3-1.21
Other Long-Term Assets
7.236.85.428.275.114.99
Total Assets
2,9792,9563,0263,2402,9962,970

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
373.21292.26307.43246.82402.69460.8
Accrued Expenses
22.7219.7813.132.1127.1324.33
Short-Term Debt
574.25609.59642.56634.11590.14477.48
Current Portion of Long-Term Debt
-40.6419.746.2233.8945.17
Current Portion of Leases
-18.0519.452.762.61.99
Current Income Taxes Payable
-4.871.44.085.2510.6
Current Unearned Revenue
4.494.714.795.5810.4718.06
Other Current Liabilities
69.9215.9715.2515.0712.2816.55
Total Current Liabilities
1,0451,0061,024986.761,0841,055
Long-Term Debt
116.48133.7774.28108.34122.7161.97
Long-Term Leases
-1.1221.6954.381.011.89
Long-Term Unearned Revenue
17.3618.1921.3324.5515.1617.76
Long-Term Deferred Tax Liabilities
--0.670.771.471.09
Total Liabilities
1,1781,1591,1421,1751,2251,238

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
189.7189.7189.7189.7106.92107.25
Additional Paid-In Capital
1,2771,2771,2771,2771,1081,117
Retained Earnings
327.58295.52372.46546.6502.77462.32
Treasury Stock
-30-----7.99
Comprehensive Income & Other
----1.12.634.34
Total Common Equity
1,7641,7621,8392,0121,7201,683
Minority Interest
35.9434.5145.0453.2950.7449.28
Shareholders' Equity
1,8001,7971,8842,0651,7711,732
Total Liabilities & Equity
2,9792,9563,0263,2402,9962,970

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
690.72803.17777.68845.81750.35688.5
Net Cash (Debt)
-456.67-508.1-521.72-607.32-561.95-527
Net Cash Growth
------
Net Cash Per Share
-2.42-2.71-2.76-3.33-3.21-3.09
Filing Date Shares Outstanding
204.71189.7189.7189.7171.08171.6
Total Common Shares Outstanding
204.71189.7189.7189.7171.08171.6
Working Capital
247.71278.66261.24411.0355.4825.31
Book Value Per Share
8.629.299.6910.6110.059.81
Tangible Book Value
1,5861,5791,6501,8121,5471,504
Tangible Book Value Per Share
7.758.338.709.559.048.76
Buildings
-663.65551.52593.55582.43535.73
Machinery
-1,5351,5031,51169.211,284
Construction In Progress
-231.26281.7279.29292.42356.9